Chemotherapy dose intensity in non-Hodgkin's lymphoma: is dose intensity an emerging paradigm for better outcomes?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Chemotherapy dose intensity in non-Hodgkin's lymphoma: is dose intensity an emerging paradigm for better outcomes?

Published:2005-09 Issue:9 Volume:16 Page:1413-1424
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Gregory S.A.,Trümper L.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/16/9/1413/433096/mdi264.pdf

Reference60 articles.

1. Hydroxyldaunomycin (Adriamycin) combination chemotherapy in malignant lymphoma;McKelvey;Cancer,1976

2. Prognostic significance of actual dose intensity in diffuse large-cell lymphoma: results of a tree-structured survival analysis;Kwak;J Clin Oncol,1990

3. Survival of diffuse large cell lymphoma. A multivariate analysis including dose intensity variables;Epelbaum;Cancer,1990

4. Prognostic significance of received relative dose intensity in non-Hodgkin's lymphoma patients: application to LNH-87 protocol. The GELA (Groupe d'Etude des Lymphomes de l'Adulte);Lepage;Ann Oncol,1993

5. Doxorubicin-based chemotherapy for diffuse large B-cell lymphoma in elderly patients: comparison of treatment outcomes between young and elderly patients and the significance of doxorubicin dosage;Lee;Cancer,2003

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. User-designed device with programmable release profile for localized treatment;Journal of Controlled Release;2022-12

2. Treatment outcomes and relative dose intensity of chemotherapy in patients with advanced Hodgkin lymphoma;Oncology Letters;2022-07-19

3. Prevalence of Major Cardiac Events of Anthracycline-Induced Cardiotoxicity in Southwestern Iran: Different Response Patterns to Cumulative Dose;Current Drug Therapy;2020-01-14

4. Improved survival in overweight and obese patients with aggressive B-cell lymphoma treated with rituximab-containing chemotherapy for curative intent;Leukemia & Lymphoma;2018-12-05

5. Protocol for the P3BEP trial (ANZUP 1302): an international randomised phase 3 trial of accelerated versus standard BEP chemotherapy for adult and paediatric male and female patients with intermediate and poor-risk metastatic germ cell tumours;BMC Cancer;2018-08-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3